Loading clinical trials...
Loading clinical trials...
Phase 0 Trial of [F-18]-5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine
Conditions
Interventions
[F-18]-5-FLUORO-2'-DEOXYCYTIDINE
Tetrahydrouridine intravenous (IV)
+2 more
Locations
1
United States
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
Start Date
November 1, 2011
Primary Completion Date
August 4, 2017
Completion Date
January 11, 2019
Last Updated
June 2, 2020
NCT07143110
NCT07222488
NCT06885697
NCT04577599
NCT05614739
NCT06998069
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions